insights_auto
Why is MRNA down 6.28%?
Dive Deeperchevron_right
MRNA:NASDAQ
Moderna Inc
$ 190.69
arrow_downward
-6.28%(-12.77) 1D
9-р сарын 30, 13:28:39 (GMT-4) · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRNA...
Open
$ 186.55
High
$ 196.83
Low
$ 184.58
Mkt. cap
76.13 тэрбум
Avg. vol.
28.77 сая
Volume
13.70 сая
52-wk high
$ 208.90
52-wk low
$ 22.29
EPS
-$ 7.98
Beta
1.10
Shares outstanding
399.24 сая
No. of employees
5 мян
Open
$ 186.55
High
$ 196.83
Low
$ 184.58
Mkt. cap
76.13 тэрбум
Avg. vol.
28.77 сая
Volume
13.70 сая
52-wk high
$ 208.90
52-wk low
$ 22.29
EPS
-$ 7.98
Beta
1.10
Shares outstanding
399.24 сая
No. of employees
5 мян
News stories
From web sources and news partners
Benzinga
·
41 минутын өмнө
Nasdaq 100 Climbs as Cooler PCE Cuts Rate Hike Bets, Micron Earnings Loom: Stock Market Today
News Corp
·
47 минутын өмнө
Moderna Stock Has Run Too Far, Too Fast. Why Citi Just Downgraded It to Sell.
Zacks Investment Research
·
1 цагийн өмнө
Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now?
Zacks
·
1 цагийн өмнө
Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now?
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
About Moderna Inc